US2021284644A1PendingUtilityA1

Nitrogen-containing heterocyclic amide compound and pharmaceutical use thereof

Assignee: JAPAN TOBACCO INCPriority: Feb 1, 2018Filed: Oct 8, 2020Published: Sep 16, 2021
Est. expiryFeb 1, 2038(~11.5 yrs left)· nominal 20-yr term from priority
C07D 519/00A61P 9/04C12N 9/99A61P 35/00A61P 3/10C07D 498/04A61K 31/4725A61K 31/506A61P 9/12A61P 25/00C07D 487/04A61P 9/10A61K 31/437A61K 31/4985A61P 43/00A61P 11/00A61P 21/00A61P 19/00A61P 3/00A61P 3/06
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a compound having a PDHK inhibitory activity and useful for the treatment or prophylaxis of diabetes (type 1 diabetes, type 2 diabetes etc.), insulin resistance syndrome, metabolic syndrome, hyperglycemia, hyperlactacidemia, diabetic complications (diabetic neuropathy, diabetic retinopathy, diabetic nephropathy, cataract etc.), cardiac failure (acute cardiac failure, chronic cardiac failure), cardiomyopathy, myocardial ischemia, myocardial infarction, angina pectoris, dyslipidemia, atherosclerosis, peripheral arterial disease, intermittent claudication, chronic obstructive pulmonary disease, brain ischemia, cerebral apoplexy, mitochondrial disease, mitochondrial encephalomyopathy, cancer, pulmonary hypertension or Alzheimer disease. The present invention relates to a compound of the formula [I-a] or the formula [II], or a pharmaceutically acceptable salt thereof:wherein each symbol means the same as that described in the specification.

Claims

exact text as granted — not AI-modified
1 .- 35 . (canceled) 
     
     
         36 . A method for producing a compound represented by formula [I-a]: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof, wherein the method comprises a step of performing an amidation reaction of a compound presented by formula [2]: 
       
         
           
           
               
               
           
         
       
       and a compound represented by formula [17]: 
       
         
           
           
               
               
           
         
       
       wherein
 a bond in a dotted line is a single bond or a double bond, 
 X 1  is a carbon atom, a nitrogen atom or an oxygen atom, 
 X 2  is a carbon atom or a nitrogen atom, 
 R 1a  is C 1-4  alkyl or C 1-4  alkylcarbonyl, 
 R 2  is halogen, cyano or C 1-4  alkyl, 
 m is 0 or 1, 
 n is 0, 1 or 2, when n is 2, each R 2  is the same or different, 
 A 1 , A 2 , A 3 , A 4 , A 5 , A 6  and A 7  are each independently selected from a carbon atom, a nitrogen atom and an oxygen atom, A 8  is selected from a carbon atom and a nitrogen atom, and a total number of nitrogen and oxygen atoms contained in a partial structural formula: 
 
       
         
           
           
               
               
           
         
         is 0, 1, 2 or 3, 
         t is 0 or 1, 
         r is 0, 1 or 2, and a total of t and r is 1 or 2, and 
         w is 0 or 1. 
       
     
     
         37 . A compound represented by formula (17):

Join the waitlist — get patent alerts

Track US2021284644A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.